[1]
|
Lim, S.S., Vos, T., Flaxman, A.D., Danaei, G., Shibuya, K., Adair-Rohani, H., et al. (2012) A Comparative Risk Assessment of Burden of Disease and Injury Attributable to 67 Risk Factors and Risk Factor Clusters in 21 Regions, 1990-2010: A Systematic Analysis for the Global Burden of Disease Study 2010. Lancet, 380, 2224-2260. https://doi.org/10.1016/S0140-6736(12)61766-8
|
[2]
|
Mozaffarian, D. and Willett, W.C. (2007) Trans Fatty Acids and Cardiovascular Risk: A Unique Cardiometabolic Imprint? Current Atherosclerosis Reports, 9, 486-493. https://doi.org/10.1007/s11883-007-0065-9
|
[3]
|
Mozaffarian, D., Micha, R. and Wallace, S. (2010) Effects on Coronary Heart Disease of Increasing Polyunsaturated Fat in Place of Saturated Fat: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. PLoS Medicine, 7, e1000252. https://doi.org/10.1371/journal.pmed.1000252
|
[4]
|
Jakobsen, M.U., O’Reilly, E.J., Heitmann, B.L., Pereira, M.A., Bälter, K., Fraser, G.E., et al. (2009) Major Types of Dietary Fat and Risk of Coronary Heart Disease: A Pooled Analysis of 11 Cohort Studies. The American Journal of Clinical Nutrition, 89, 1425-1432.
|
[5]
|
Farvid, M.S., Ding, M., Pan, A., Sun, Q., Chiuve, S.E., Steffen, L.M., et al. (2014) Dietary Linoleic acid and Risk of Coronary Heart Disease: A Systematic Review and Meta-Analysis of Prospective Cohort Studies. Circulation, 130, 1568-1578.
https://doi.org/10.1161/CIRCULATIONAHA.114.010236
|
[6]
|
Chowdhury, R., Warnakula, S., Kunutsor, S., Crowe, F., Ward, H.A., Johnson, L., et al. (2014) Association of Dietary, Circulating, and Supplement Fatty Acids with Coronary Risk: A Systematic Review and Meta-Analysis. Annals of Internal Medicine, 160, 398-406. https://doi.org/10.7326/M13-1788
|
[7]
|
Benjamin, E.J., Blaha, M.J., Chiuve, S.E., Cushman, M., Das, S.R., Deo, R., et al. (2017) Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation, 135, e146-e603.
https://doi.org/10.1161/CIR.0000000000000485
|
[8]
|
Carnethon, M.R., De Chavez, P.J., Zee, P.C., Kim, K.Y., Liu, K., Goldberger, J.J., et al. (2016) Disparities in Sleep Characteristics by Race/Ethnicity in a Population-Based Sample: Chicago Area Sleep Study. Sleep Medicine, 18, 50-55.
https://doi.org/10.1016/j.sleep.2015.07.005
|
[9]
|
Chaudhary, R, Saadin, K., Bliden, K.P., Harris, W.S., Dinh, B., Sharma, T., et al. (2016) Risk Factors Associated with Plasma Omega-3 Fatty Acid Levels in Patients with Suspected Coronary Artery Disease. Prostaglandins, Leukotrienes, and Essential Fatty Acids, 113, 40-45. https://doi.org/10.1016/j.plefa.2016.08.009
|
[10]
|
Allaire, J., Harris, W.S., Vors, C., Charest, A, Marin, J., Jackson, K.H., et al. (2017) Supplementation with High-Dose Docosahexaenoic Acid Increases the Omega-3 Index More than High-Dose Eicosapentaenoic Acid. Prostaglandins, Leukotrienes, and Essential Fatty Acids, 120, 8-14. https://doi.org/10.1016/j.plefa.2017.03.008
|
[11]
|
Hussein, N., Ah-Sing, E., Wilkinson, P., Leach, C., Griffin, B.A. and Millward, D.J. (2005) Long-Chain Conversion of [13C]linoleic Acid and Alpha-Linolenic Acid in Response to Marked Changes in Their Dietary Intake in Men. Journal of Lipid Research, 46, 269-280. https://doi.org/10.1194/jlr.M400225-JLR200
|
[12]
|
Iso, H., Kobayashi, M., Ishihara, J., Sasaki, S., Okada, K., Kita, Y., et al. (2006) Intake of Fish and n3 Fatty Acids and Risk of Coronary Heart Disease among Japanese: The Japan Public Health Center-Based (JPHC) Study Cohort I. Circulation, 113, 195-202. https://doi.org/10.1161/CIRCULATIONAHA.105.581355
|
[13]
|
Sekikawa, A., Miura, K., Lee, S., Fujiyoshi, A., Edmundowicz, D., Kadowaki, T., et al. (2014) Long Chain n-3 Polyunsaturated Fatty Acids and Incidence Rate of Coronary Artery Calcification in Japanese Men in Japan and White Men in the USA: Population Based Prospective Cohort Study. Heart, 100, 569-573.
https://doi.org/10.1136/heartjnl-2013-304421
|
[14]
|
Sekikawa, A., Horiuchi, B.Y., Edmundowicz, D., Ueshima, H., Curb, J.D., Sutton-Tyrrell, K., et al. (2003) A “Natural Experiment” in Cardiovascular Epidemiology in the Early 21st Century. Heart, 89, 255-257.
https://doi.org/10.1136/heart.89.3.255
|
[15]
|
Aung, T., Halsey, J., Kromhout, D., Gerstein, H.C., Marchioli, R., Tavazzi, L., et al. (2018) Associations of Omega-3 Fatty Acid Supplement Use with Cardiovascular Disease Risks: Meta-Analysis of 10 Trials Involving 77917 Individuals. JAMA Cardiology, 3, 225-234.
|
[16]
|
Marchioli, R. and Levantesi, G. (2013) n-3 PUFAs in Cardiovascular Disease. International Journal of Cardiology, 170, S33-S38.
https://doi.org/10.1016/j.ijcard.2013.06.042
|
[17]
|
Bowen, K.J., Harris, W.S. and Kris-Etherton, P.M. (2016) Omega-3 Fatty Acids and Cardiovascular Disease: Are There Benefits? Current Treatment Options in Cardiovascular Medicine, 18, 69. https://doi.org/10.1007/s11936-016-0487-1
|
[18]
|
Wu, J.H. and Mozaffarian, D. (2014) Omega-3 Fatty Acids, Atherosclerosis Progression and Cardiovascular Outcomes in Recent Trials: New Pieces in a Complex Puzzle. Heart, 100, 530-533. https://doi.org/10.1136/heartjnl-2013-305257
|
[19]
|
Alexander, D.D., Miller, P.E., Van Elswyk, M.E., Kuratko, C.N. and Bylsma, L.C. (2017) A Meta-Analysis of Randomized Controlled Trials and Prospective Cohort Studies of Eicosapentaenoic and Docosahexaenoic Long-Chain Omega-3 Fatty Acids and Coronary Heart Disease Risk. Mayo Clinic Proceedings, 92, 15-29.
https://doi.org/10.1016/j.mayocp.2016.10.018
|
[20]
|
Maki, K.C., Palacios, O.M., Bell, M. and Toth, P.P. (2017) Use of Supplemental Long-Chain Omega-3 Fatty Acids and Risk for Cardiac Death: An Updated Meta-Analysis and Review of Research Gaps. Journal of Clinical Lipidology, 11, 1152-1160. https://doi.org/10.1016/j.jacl.2017.07.010
|
[21]
|
Del Gobbo, L.C., Imamura, F., Aslibekyan, S., Marklund, M., Virtanen, J.K., Wennberg, M., et al. (2016) Omega-3 Polyunsaturated Fatty Acid Biomarkers and Coronary Heart Disease: Pooling Project of 19 Cohort Studies. JAMA Internal Medicine, 176, 1155-1166. https://doi.org/10.1001/jamainternmed.2016.2925
|
[22]
|
Harris, W.S., Del Gobbo, L. and Tintle, N.L. (2017) The Omega-3 Index and Relative Risk for Coronary Heart Disease Mortality: Estimation from 10 Cohort Studies. Atherosclerosis, 262, 51-54. https://doi.org/10.1016/j.atherosclerosis.2017.05.007
|
[23]
|
Lemaitre, R.N., King, I.B., Mozaffarian, D., Kuller, L.H., Tracy, R.P. and Siscovick, D.S. (2006) Plasma Phospholipid Trans Fatty Acids, Fatal Ischemic Heart Disease, and Sudden Cardiac Death in Older Adults: The Cardiovascular Health Study. Circulation, 114, 209-215. https://doi.org/10.1161/CIRCULATIONAHA.106.620336
|
[24]
|
Kleber, M.E., Delgado, G.E., Lorkowski, S., März, W. and von Schacky, C. (2016) Trans-Fatty Acids and Mortality in Patients Referred for Coronary Angiography: The Ludwigshafen Risk and Cardiovascular Health Study. European Heart Journal, 37, 1072-1078. https://doi.org/10.1093/eurheartj/ehv446
|
[25]
|
Wang, Q., Afshin, A., Yakoob, M.Y., Singh, G.M., Rehm, C.D., Khatibzadeh, S., et al. (2016) Impact of Nonoptimal Intakes of Saturated, Polyunsaturated, and Trans Fat on Global Burdens of Coronary Heart Disease. Journal of the American Heart Association, 5, pii: e002891. https://doi.org/10.1161/JAHA.115.002891
|
[26]
|
Arab, L. (2003) Biomarkers of Fat and Fatty Acid Intake. The Journal of Nutrition, 133, 925S-932S. https://doi.org/10.1093/jn/133.3.925S
|
[27]
|
El-Saed, A., Masaki, K., Okamura, T., Evans, R.W., Nakamura, Y., Willcox, B.J., et al. (2016) The Associations of C-Reactive Protein with Serum Levels of Polyunsaturated Fatty Acids and Trans Fatty Acids among Middle-Aged Men from Three Populations. The Journal of Nutrition, Health & Aging, 20, 16-21.
https://doi.org/10.1007/s12603-016-0670-9
|
[28]
|
Mori, K., Ishida, T., Yasuda, T., Hasokawa, M., Monguchi, T., Sasaki, M., et al. (2015) Serum Trans-Fatty Acid Concentration Is Elevated in Young Patients with Coronary Artery Disease in Japan. Circulation Journal: Official Journal of the Japanese Circulation Society, 79, 2017-2025.
|